Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant lymphomas in the elderly

S E O'Reilly1, J M Connors, N Macpherson

  • 1Division of Medical Oncology, Vancouver Cancer Center, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6 Canada. Hospital and Health Sciences Center,

Clinics in Geriatric Medicine
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative assessment of radiation therapy-induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy.

European journal of nuclear medicine and molecular imaging·2023
Same author

The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis.

Journal de medecine vasculaire·2022
Same author

Cancer and thrombosis: new insights to an old problem.

Journal de medecine vasculaire·2020
Same author

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.

Journal de medecine vasculaire·2020
Same author

New progress in the treatment and prophylaxis of venous thrombo-embolism in cancer patients.

Journal de medecine vasculaire·2020
Same author

Hodgkin lymphoma, treatment and thrombosis: a dangerous mix.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same journal

Cardiovascular Prevention in Older Adults: From Estimation to Treatment.

Clinics in geriatric medicine·2026
Same journal

Preventive Cardiology for the Clinically Complex Older Adult.

Clinics in geriatric medicine·2026
Same journal

A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

Clinics in geriatric medicine·2026
Same journal

Secondary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Primary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

Clinics in geriatric medicine·2026
See all related articles

Older adults with lymphoma, particularly those over 65, can benefit from tailored chemotherapy. Shorter treatment courses, like 8-week regimens, show similar efficacy to standard chemotherapy for aggressive lymphomas.

Area of Science:

  • Oncology
  • Hematology
  • Geriatric Medicine

Background:

  • Lymphomas are frequently diagnosed in older adults, with over half of cases occurring in patients aged 60 and above.
  • Age is a recognized adverse prognostic factor in lymphoma patient outcomes.
  • Management strategies for elderly lymphoma patients require careful consideration of age-related factors.

Purpose of the Study:

  • To review the management of low-grade and aggressive histology lymphomas in patients over 65.
  • To discuss treatment options considering age, performance status, and comorbidities.
  • To highlight the efficacy and tolerability of chemotherapy regimens in this demographic.

Main Methods:

  • Review of current literature on lymphoma management in elderly patients.

Related Experiment Videos

  • Analysis of treatment outcomes for low-grade and aggressive lymphomas.
  • Evaluation of chemotherapy regimens, including cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP).

    • Main Results:

    • Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy is generally well-tolerated in older patients with good performance status and aggressive lymphomas.
    • Briefer 8-week chemotherapy regimens demonstrate comparable benefits to longer courses, offering quicker treatment delivery.
    • Age-adjusted and individualized treatment plans are crucial for optimizing outcomes.

    Conclusions:

    • Effective lymphoma treatment for patients over 65 should be personalized based on age, performance status, and coexisting medical conditions.
    • Shorter chemotherapy regimens can provide significant benefits with improved timeliness.
    • Optimizing lymphoma management in the elderly requires a tailored approach to balance treatment efficacy and patient well-being.